Researchers gain new insight on metastatic prostate cancer
An international research team has discovered a principle that explains the metastasising of prostate cancer.…
Browsing: metastatic
ESMO 2018: Immunotherapy improves survival in metastatic or recurrent head and neck cancer
Immunotherapy with pembrolizumab improves survival in patients with head and neck cancer that has recurred…
Phase II trial shows activity of durvalumab in recurrent/metastatic head and neck cancer
Analysis of the phase II CONDOR trial indicates that the immune checkpoint inhibitor durvalumab is…
Study provides path for new immunotherapy approaches to prostate cancer
Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways…